Eris Lifesciences to acquire nine dermatology brands of Glenmark Pharmaceuticals for $42m.

Synopsis

Eris Lifesciences, a pharmaceutical company, agreed to acquire nine dermatology brands of Glenmark Pharmaceuticals, a pharmaceutical company, for $42m.

Principals

target

Glenmark Pharmaceuticals (nine Dermatology Brands)

bidder

Eris Lifesciences

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Market Context

khaitan & co

HQ - Kolkata, India

legal advisors

bidder

784

Deals

£ 168.10 B

Total Value